Application of Purified Botulinum Type A Neurotoxin to Treat Experimental Trigeminal Neuropathy in Rats and Patients with Urinary Incontinence and Prostatic Hyperplasia
Type A neurotoxin (NTX) of Clostridium botulinum was purified by a simple procedure using a lactose gel column. The toxicity of this purified toxin preparation was retained for at least 1 year at −30°C by supplementation with either 0.1% albumin or 0.05% albumin plus 1% trehalose. When purified NTX...
Saved in:
Main Authors: | Yoshizo Matsuka, Teruhiko Yokoyama, Yumiko Yamamoto, Tomonori Suzuki, Ni Nengah Dwi Fatmawati, Atsushi Nishikawa, Tohru Ohyama, Toshihiro Watanabe, Takuo Kuboki, Atsushi Nagai, Keiji Oguma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Toxicology |
Online Access: | http://dx.doi.org/10.1155/2012/648384 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blockade of Glutamate Release by Botulinum Neurotoxin Type A in Humans: A Dermal Microdialysis Study
by: Larissa Bittencourt da Silva, et al.
Published: (2014-01-01) -
New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
by: Marina Vladimirovna Silkina, et al.
Published: (2024-07-01) -
Development of a Cell-Based Functional Assay for the Detection of Clostridium botulinum Neurotoxin Types A and E
by: Uma Basavanna, et al.
Published: (2013-01-01) -
Botulinum Neurotoxin Type A for the Treatment of Benign Prostatic Hyperplasia: Randomized Study Comparing Two Doses
by: René Arnouk, et al.
Published: (2012-01-01) -
Botulinum Neurotoxin Application to the Severed Femoral Nerve Modulates Spinal Synaptic Responses to Axotomy and Enhances Motor Recovery in Rats
by: Marcel Irintchev, et al.
Published: (2018-01-01)